EurekaMag.com logo
+ Site Statistics
References:
53,623,987
Abstracts:
29,492,080
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Multicenter trial of a new protocol without etoposide for patients with multifocal Langerhans cell histiocytosis in Japan



Multicenter trial of a new protocol without etoposide for patients with multifocal Langerhans cell histiocytosis in Japan



Medical & Pediatric Oncology 36(3): 418, March




(PDF 0-2 workdays service: $29.90)

Accession: 035349957

Download citation: RISBibTeXText



Related references

Improved outcome in the treatment of pediatric multifocal Langerhans cell histiocytosis: Results from the Japan Langerhans Cell Histiocytosis Study Group-96 protocol study. Cancer 107(3): 613-619, 2006

Intensification of induction therapy and prolongation of maintenance therapy did not improve the outcome of pediatric Langerhans cell histiocytosis with single-system multifocal bone lesions: results of the Japan Langerhans Cell Histiocytosis Study Group-02 Protocol Study. International Journal of Hematology, 2018

Intensified and prolonged therapy comprising cytarabine, vincristine and prednisolone improves outcome in patients with multisystem Langerhans cell histiocytosis: results of the Japan Langerhans Cell Histiocytosis Study Group-02 Protocol Study. International Journal of Hematology 104(1): 99-109, 2016

Treatment of children with multiple system Langerhans cell histiocytosis by Japan Langerhans Cell Histiocytosis Study Group Protocol. Zhongguo Shi Yan Xue Ye Xue Za Zhi 21(1): 146-149, 2013

LCH-I: A randomized trial of etoposide vs. vinblastine in disseminated Langerhans cell histiocytosis. Medical and Pediatric Oncology 23(2): 107-110, 1994

Therapeutic outcome of multifocal Langerhans cell histiocytosis in adults treated with the Special C regimen formulated by the Japan LCH Study Group. International Journal of Hematology 97(1): 103-108, 2013

Etoposide vp 16 an effective therapeutic regimen for disseminated langerhans cell histiocytosis histiocytosis x. Pediatric Research 29(4 PART 2): 154A, 1991

Re: "Etoposide in the treatment of six children with Langerhans cell histiocytosis (histiocytosis X)" by Viana et al. Medical and Pediatric Oncology 21(5): 379-379, 1993

Successful treatment of multisystem Langerhans cell histiocytosis (histiocytosis X) with etoposide. American Journal of Pediatric Hematology/Oncology 16(3): 275-277, 1994

Etoposide in the treatment of six children with langerhans cell histiocytosis (histiocytosis X) by Viana et al. Pediatric Blood & Cancer 21(5): 379-379, 1993

Etoposide (VP16) in the treatment of multisystem Langerhans cell histiocytosis (histiocytosis X). Medical and Pediatric Oncology 17(2): 97-100, 1989

Etoposide in the treatment of six children with Langerhans cell histiocytosis (histiocytosis X). Medical and Pediatric Oncology 19(4): 289-294, 1991

Diffuse xanthogranulomatous dermatitis and systemic Langerhans cell histiocytosis: A novel case that demonstrates bridging between non-Langerhans cell histiocytosis and Langerhans cell histiocytosis. Journal of the American Academy of Dermatology 60(5): 841-848, 2008

Two case report studies of Langerhans cell histiocytosis with an analysis of 918 patients of Langerhans cell histiocytosis in literatures published in China. International Journal of Dermatology 49(10): 1169-1174, 2011

Monosystem multifocal Langerhans cell histiocytosis (multifocal eosinophilic granulomas of the bone) in a 36-year old patient: case report, therapeutic doubts and review of literature. Collegium Antropologicum 37(2): 521-525, 2013